This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: The Innovations of Michael Winter
Introduction
Michael Winter is a notable inventor based in Freiburg, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of hematological disorders. His innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Michael Winter holds a patent for GlyT1 inhibitors for use in the treatment of hematological disorders. This invention focuses on compounds that serve as GlyT1 inhibitors, specifically targeting conditions such as sickle cell disease and thalassemia. Additionally, his work addresses the treatment of patients with iron overload syndromes, including hereditary hemochromatosis.
Career Highlights
Throughout his career, Michael Winter has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has contributed to his expertise in developing innovative treatments.
Collaborations
Michael has collaborated with several professionals in his field, including Daniela Alberati and Annette Koerner. These partnerships have enhanced his research and development efforts, leading to advancements in medical treatments.
Conclusion
Michael Winter's contributions to the field of medicine through his innovative patents and collaborations highlight his commitment to improving healthcare. His work continues to impact the treatment of hematological disorders significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile